ATE442842T1 - Verwendung von urokinase-inhibitoren zur behandlung und/oder vorbeugung von amyotrophischer lateralsklerose (als) - Google Patents
Verwendung von urokinase-inhibitoren zur behandlung und/oder vorbeugung von amyotrophischer lateralsklerose (als)Info
- Publication number
- ATE442842T1 ATE442842T1 AT06754517T AT06754517T ATE442842T1 AT E442842 T1 ATE442842 T1 AT E442842T1 AT 06754517 T AT06754517 T AT 06754517T AT 06754517 T AT06754517 T AT 06754517T AT E442842 T1 ATE442842 T1 AT E442842T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- lateral sclerosis
- amyotrophic lateral
- urocinasis
- als
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69343205P | 2005-06-24 | 2005-06-24 | |
| PCT/EP2006/006029 WO2006136419A2 (en) | 2005-06-24 | 2006-06-22 | Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442842T1 true ATE442842T1 (de) | 2009-10-15 |
Family
ID=37570795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06754517T ATE442842T1 (de) | 2005-06-24 | 2006-06-22 | Verwendung von urokinase-inhibitoren zur behandlung und/oder vorbeugung von amyotrophischer lateralsklerose (als) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8093258B2 (de) |
| EP (2) | EP1893185B1 (de) |
| JP (1) | JP2008543900A (de) |
| KR (1) | KR20080027875A (de) |
| AT (1) | ATE442842T1 (de) |
| AU (1) | AU2006261099A1 (de) |
| CA (1) | CA2612262A1 (de) |
| DE (1) | DE602006009257D1 (de) |
| ES (1) | ES2329286T3 (de) |
| HK (1) | HK1109862A1 (de) |
| MX (1) | MX2007016439A (de) |
| RU (1) | RU2410087C2 (de) |
| WO (1) | WO2006136419A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3139850A1 (en) * | 2019-05-10 | 2020-11-19 | Talengen International Limited | Method and medicine for treating amyotrophic lateral sclerosis |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340833A (en) | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
| US5550213A (en) | 1993-12-27 | 1996-08-27 | Rutgers, The State University Of New Jersey | Inhibitors of urokinase plasminogen activator |
| US5952307A (en) | 1994-01-21 | 1999-09-14 | Georgia Tech Research Corp. | Basic α-aminoalkylphosphonate derivatives |
| CH689611A5 (de) | 1995-03-01 | 1999-07-15 | Pentapharm Ag | Urokinase-Inhibitoren. |
| AUPO227896A0 (en) | 1996-09-13 | 1996-10-03 | Fujisawa Pharmaceutical Co., Ltd. | Novel compounds and their preparation |
| ATE247130T1 (de) | 1997-04-11 | 2003-08-15 | Wilex Ag | Inhibitoren für den urokinaserezeptor |
| ZA986594B (en) | 1997-07-25 | 1999-01-27 | Abbott Lab | Urokinase inhibitors |
| GB9721964D0 (en) | 1997-10-16 | 1997-12-17 | Pfizer Ltd | Isoquinolines |
| AU765072B2 (en) | 1998-02-09 | 2003-09-11 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| BR9912327B1 (pt) | 1998-07-20 | 2013-11-12 | Inibidores da uroquinase | |
| US6576613B1 (en) | 1998-07-24 | 2003-06-10 | Corvas International, Inc. | Title inhibitors of urokinase |
| WO2000005214A2 (en) | 1998-07-24 | 2000-02-03 | Pfizer Inc. | Isoquinolines as urokinase inhibitors |
| WO2000006154A1 (fr) | 1998-07-29 | 2000-02-10 | Taiho Pharmaceutical Company, Ltd. | Inhibiteurs de la production d'urokinase, inhibiteurs de l'angiogenese et procedes de prevention ou de traitement les utilisant |
| WO2000017158A1 (de) | 1998-09-18 | 2000-03-30 | Pentapharm Ag | Urokinase-inhibitoren |
| GB9908410D0 (en) | 1999-04-13 | 1999-06-09 | Pfizer Ltd | Pyridines |
| DE19940389A1 (de) | 1999-08-25 | 2001-03-01 | Wilex Biotechnology Gmbh | Selektive Inhibitoren des Urokinase-Plasminogen Aktivators |
| EP1242366A1 (de) | 1999-12-15 | 2002-09-25 | Axys Pharmaceuticals, Inc. | Salicylamide als serine-protease- und factor-xa-inhibitoren |
| US6207701B1 (en) | 2000-01-28 | 2001-03-27 | Abbott Laboratories | Urokinase inhibitors |
| DE10013715A1 (de) | 2000-03-20 | 2001-09-27 | Wilex Biotechnology Gmbh | Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators |
| DE10029014A1 (de) | 2000-06-15 | 2001-12-20 | Univ Schiller Jena | Urokinase-Hemmstoffe |
| DE60034447T2 (de) | 2000-08-11 | 2008-02-14 | Wilex Ag | Nicht-kovalente Urokinase-und Angiogenese-Inhibitoren |
| CA2387002A1 (en) | 2000-08-11 | 2002-02-21 | Corvas International, Inc. | Non-covalent inhibitors of urokinase and blood vessel formation |
| ATE386029T1 (de) | 2001-03-21 | 2008-03-15 | Wilex Ag | Urokinase-inhibitoren |
| AU2002364713A1 (en) | 2001-12-04 | 2003-06-17 | Corvas International, Inc. | Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation |
| EP1453852B1 (de) | 2001-12-12 | 2007-01-17 | Wilex AG | Selektive arylguanidinpeptide als urokinaseinhibitoren |
| AU2003219039A1 (en) | 2002-03-11 | 2003-09-22 | Curacyte Ag | Urokinase inhibitors, production and use thereof |
| DE10225876A1 (de) | 2002-06-11 | 2003-12-24 | Wilex Ag | Guanidinophenylalaninverbindungen als Urokinase-Inhibitoren |
| MXPA05011762A (es) * | 2003-05-05 | 2006-03-30 | Paion Deutschland Gmbh | Antagonistas de receptor de glutamato como neuroprotectores. |
| DE10323898A1 (de) | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
-
2006
- 2006-06-22 EP EP06754517A patent/EP1893185B1/de not_active Not-in-force
- 2006-06-22 WO PCT/EP2006/006029 patent/WO2006136419A2/en active Application Filing
- 2006-06-22 MX MX2007016439A patent/MX2007016439A/es active IP Right Grant
- 2006-06-22 AT AT06754517T patent/ATE442842T1/de active
- 2006-06-22 ES ES06754517T patent/ES2329286T3/es active Active
- 2006-06-22 KR KR1020087001816A patent/KR20080027875A/ko not_active Application Discontinuation
- 2006-06-22 JP JP2008517418A patent/JP2008543900A/ja active Pending
- 2006-06-22 US US11/922,774 patent/US8093258B2/en not_active Expired - Fee Related
- 2006-06-22 DE DE602006009257T patent/DE602006009257D1/de active Active
- 2006-06-22 AU AU2006261099A patent/AU2006261099A1/en not_active Abandoned
- 2006-06-22 CA CA002612262A patent/CA2612262A1/en not_active Abandoned
- 2006-06-22 RU RU2008102730/15A patent/RU2410087C2/ru not_active IP Right Cessation
- 2006-06-22 EP EP09001466A patent/EP2087885A1/de not_active Withdrawn
-
2008
- 2008-04-10 HK HK08104029.9A patent/HK1109862A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090069251A1 (en) | 2009-03-12 |
| EP1893185A2 (de) | 2008-03-05 |
| HK1109862A1 (en) | 2008-06-27 |
| EP2087885A1 (de) | 2009-08-12 |
| EP1893185B1 (de) | 2009-09-16 |
| RU2008102730A (ru) | 2009-07-27 |
| ES2329286T3 (es) | 2009-11-24 |
| WO2006136419B1 (en) | 2007-05-31 |
| DE602006009257D1 (de) | 2009-10-29 |
| AU2006261099A1 (en) | 2006-12-28 |
| WO2006136419A3 (en) | 2007-04-19 |
| CA2612262A1 (en) | 2006-12-28 |
| MX2007016439A (es) | 2008-03-04 |
| KR20080027875A (ko) | 2008-03-28 |
| JP2008543900A (ja) | 2008-12-04 |
| WO2006136419A2 (en) | 2006-12-28 |
| US8093258B2 (en) | 2012-01-10 |
| RU2410087C2 (ru) | 2011-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118597T1 (el) | Συνθεσεις οι οποιες περιεχουν λιπαση, πρωτεαση και αμυλαση για αντιμετωπιση παγκρεατικης ανεπαρκειας | |
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| DE602006012013D1 (de) | Proteasom-hemmer und verwendungsverfahren dafür | |
| CY1109551T1 (el) | Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων | |
| ATE447574T1 (de) | 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes | |
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| ATE481969T1 (de) | Aminopiperidine als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes | |
| ATE353880T1 (de) | Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate | |
| DE602004009295D1 (de) | 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie | |
| ATE521608T1 (de) | Glucokinaseaktivatoren | |
| ATE415397T1 (de) | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
| EA200870380A1 (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета | |
| MA30872B1 (fr) | Compositions d'inhibiteurs de la chk1. | |
| ATE529427T1 (de) | Ä1h-indol-5-yl)-heteroaryloxyü-(1-aza-bicyclo- ä3.3.1ü-nonane als cholinergische liganden des n- achr zur behandlung psychotischer und neurodegenerativer leiden | |
| CY1107342T1 (el) | Χρηση παραγωγων νιτριλιου ως φαρμακο | |
| ATE448775T1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| ATE542535T1 (de) | Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten | |
| TW200700057A (en) | Alpha ketoamide compounds as cysteine protease inhibitors | |
| ATE445644T1 (de) | Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten | |
| ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| ATE473277T1 (de) | Zusammensetzungen und verfahren zur prävention und behandlung von immunvermittelten entzündungskrankheiten | |
| HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
| MX2007011739A (es) | Compuestos que contienen sulfonilo como inhibidores de cisteina proteasa. | |
| DE60313803D1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
| ATE442842T1 (de) | Verwendung von urokinase-inhibitoren zur behandlung und/oder vorbeugung von amyotrophischer lateralsklerose (als) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1893185 Country of ref document: EP |